Literature DB >> 938992

Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog.

J M Jarmakani, L Limbird, T C Graham, R A Marks.   

Abstract

This study was designed to determine the effect of coronary reperfusion on (1) myocardial infarct size and (2) the accuracy of previously reported methods for estimation of infarct size serum creatine phosphokinase (CPK) values. Thirty mongrel dogs, chronically prepared, were studied in the awake state, and were divided into four groups according to the period or left circumflex coronary artery (LCCA) occlusion. Group 1: permanent occlusion (24 h) in nine dogs; group 2: 45 min occlusion (eight dogs); group 3: 1 h occlusion (five dogs); and group 4: 3 h occlusion (eight dogs). Serial blood samples were drawn for 24 h following the beginning of occlusion and were used to determine total and isoenzyme levels of CPK, and lactic dehydrogenase isoenzymes. All dogs were sacrified 24 h after the beginning of occlusion and were anatomically examined. The extent of anatomical myocardial infarction was determined and compared with the extent of myocardial infarction as estimated from serial serum CPK values. Total serum CPK increased significantly in all groups and was associated with the appearance of CPK-MB isoenzyme and an increase in LDH1,2 (LDH1 greater than LDH2) in most dogs. Total serum CPK increased within an hour after reperfusion and the mean values in groups 2, 3, and 4 were significantly high (P less than 0.05) than serum CPK values in group 1 in the period from 110 min to 4 after occlusion. These data demonstrate that reperfusion after 45 min to 3 h of coronary occlusion results in an earlier appearance of total serum CPK. The anatomical infarction in group 1 averaged 28% +/- 3% (SEM) of the total heart and was significantly larger than infarct size in all groups with reperfusion. In contrast, estimated infarction calculated from total CPK in group 1 was not significantly different from the reperfused groups. Although there was correlation between estimated and anatomical infarction, the data in each group showed that anatomical infarct size could not be accurately estimated from total serum CPK.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938992     DOI: 10.1093/cvr/10.2.245

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

1.  Recognition and quantification of myocardial injury by means of plasma enzyme and isoenzyme activities after cardiac surgery.

Authors:  A van der Laarse; H A Davids; L Hollaar; E J van der Valk; S A Witteveen; W T Hermens
Journal:  Br Heart J       Date:  1979-06

Review 2.  Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction.

Authors:  P M Guzy
Journal:  West J Med       Date:  1977-12

3.  Creatine kinase release, potassium-42 content, and mechanical performance in anoxic rabbit myocardium.

Authors:  G L Conrad; E E Rau; K I Shine
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

Review 4.  How sound is the evidence that thrombolysis increases the risk of cardiac rupture?

Authors:  D R Massel
Journal:  Br Heart J       Date:  1993-04

5.  Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase.

Authors:  S F Vatner; H Baig; W T Manders; P R Maroko
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

6.  Myocardial substrate utilization and hemodynamics following repeated coronary flow reduction in pigs.

Authors:  P D Verdouw; W J Remme; J W de Jong; W A Breeman
Journal:  Basic Res Cardiol       Date:  1979 Sep-Oct       Impact factor: 17.165

7.  Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study.

Authors:  A S Jaffe; E M Geltman; A J Tiefenbrunn; H D Ambos; H D Strauss; B E Sobel; R Roberts
Journal:  Br Heart J       Date:  1983-05

8.  Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction.

Authors:  Aslan T Turer; Kenneth W Mahaffey; Dianne Gallup; W Douglas Weaver; Robert H Christenson; Nathan R Every; E Magnus Ohman
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.